TLR4 and ovarian carcinoma: Inhibition of TLR4 significantly attenuates the proliferation of inflammatory tumour cells, a phenomenon that has been demonstrated in several studies, such as the inhibition of the expression of this gene impedes the growth of colitis-associated colon and ovarian cancer cells (Earl et al., 2009; Kashani et al., 2020).